Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Pharmacy Practice (JPP)
Sugammadex is a safe and effective medication that can be used to reverse rocuronium-induced paralysis and facilitate neurologic examination in patients with neurologic injuries. Pharmacists can play a role in ensuring that patients receive the appropriate dose of sugammadex and that it is administered in a timely manner.
Clinical Pharmacology August 31st 2023
Parkinson’s News Today
Deep brain stimulation offers a new avenue for Parkinson’s treatment but comes with its own set of lifestyle and medical considerations. Equip yourself with the knowledge to guide your patients through this transformative yet complex option.
Neurology August 30th 2023
MDLinx
The recent ruling in favor of Dr. Boarini in a malpractice suit highlights the essential role of patient history and diligent record-keeping in legal defense. Explore the details of this case to understand its implications for medical professionals.
Surgery, Neurologic August 15th 2023
Recent research suggests that precise deep brain stimulation could play a pivotal role in altering the progression of early-stage Parkinson’s disease. Take a look at the study’s findings and its implications for future treatments.
Neurology August 8th 2023
Oncology News Central (ONC)
Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.
Neurology July 18th 2023
The New England Journal of Medicine
Disability and quality of life results were comparable between decompressive craniectomy and craniotomy in individuals with traumatic acute subdural hematoma. More people in the craniotomy group underwent additional surgery, although the craniectomy group experienced more wound issues.
Neurology May 2nd 2023